ZWJ Investment Counsel Inc. acquired a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report) in the third quarter, Holdings Channel reports. The fund acquired 2,791 shares of the company’s stock, valued at approximately $201,000.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. State Board of Administration of Florida Retirement System lifted its holdings in shares of Prestige Consumer Healthcare by 77.4% during the 1st quarter. State Board of Administration of Florida Retirement System now owns 25,221 shares of the company’s stock worth $1,830,000 after acquiring an additional 11,000 shares during the period. BNP Paribas Financial Markets lifted its holdings in Prestige Consumer Healthcare by 143.4% during the 1st quarter. BNP Paribas Financial Markets now owns 51,246 shares of the company’s stock valued at $3,718,000 after purchasing an additional 30,191 shares during the last quarter. Congress Asset Management Co. MA lifted its holdings in Prestige Consumer Healthcare by 12.5% during the 1st quarter. Congress Asset Management Co. MA now owns 764,013 shares of the company’s stock valued at $55,437,000 after purchasing an additional 84,757 shares during the last quarter. Lombard Odier Asset Management USA Corp bought a new position in Prestige Consumer Healthcare during the 2nd quarter valued at about $550,000. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in Prestige Consumer Healthcare by 19.4% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 47,575 shares of the company’s stock valued at $3,453,000 after purchasing an additional 7,715 shares during the last quarter. 99.95% of the stock is owned by institutional investors.
Prestige Consumer Healthcare Trading Up 0.5 %
PBH opened at $72.30 on Friday. The company has a current ratio of 3.23, a quick ratio of 1.90 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $3.59 billion, a PE ratio of 17.34, a PEG ratio of 1.93 and a beta of 0.47. Prestige Consumer Healthcare Inc. has a 1-year low of $56.61 and a 1-year high of $75.80. The firm has a 50-day moving average price of $71.22 and a two-hundred day moving average price of $69.28.
Wall Street Analysts Forecast Growth
PBH has been the subject of several analyst reports. Jefferies Financial Group reissued a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $94.20.
View Our Latest Research Report on Prestige Consumer Healthcare
Prestige Consumer Healthcare Company Profile
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.
Recommended Stories
- Five stocks we like better than Prestige Consumer Healthcare
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Taiwan Semiconductor Soars on Earnings With More Room to Run
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Is Lucid Group Nearing the Bottom? What Investors Should Know
- How to Plot Fibonacci Price Inflection Levels
- 90% Gain Possible? Analysts Are Bullish on Joby Aviation
Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc. (NYSE:PBH – Free Report).
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.